|本期目录/Table of Contents|

[1]蒋荣猛,邓慧玲,李兴旺,等.《手足口病诊疗指南(2018 版)》解读 —— 手足口病的一般治疗与病因治疗[J].传染病信息,2018,05:421-424.
 JIANG Rong-meng,DENG Hui-ling,LI Xing-wang,et al.General treatment and etiological treatment for hand foot and mouth disease: an interpretation for Guidelines for the Diagnosis and Treatment of Hand Foot and Mouth Disease (2018 Version)[J].Infectious Disease Information,2018,05:421-424.
点击复制

《手足口病诊疗指南(2018 版)》解读 —— 手足口病的一般治疗与病因治疗(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年05期
页码:
421-424
栏目:
特别报道
出版日期:
2018-10-30

文章信息/Info

Title:
General treatment and etiological treatment for hand foot and mouth disease: an interpretation for Guidelines for the Diagnosis and Treatment of Hand Foot and Mouth Disease (2018 Version)
作者:
蒋荣猛邓慧玲李兴旺陈 强尚云晓吴星东杨巧芝俞 蕙张 婷杨 涛
100015,首都医科大学附属地坛医院感染性疾病诊 疗中心(蒋荣猛、李兴旺);710000,西安市儿童医院感染科 (邓慧玲);330006 南昌,江西省儿童医院呼吸科(陈强); 110004 沈阳,中国医科大学附属盛京医院小儿呼吸科(尚云晓); 361000,厦门市妇幼保健院儿科(吴星东);252000,聊城市 人民医院儿科(杨巧芝);201102 上海,复旦大学附属儿科 医院感染科(俞蕙);200062,上海交通大学附属儿童医院 消化科(张婷);650051,昆明市延安医院儿科(杨涛)
Author(s):
JIANG Rong-meng DENG Hui-ling LI Xing-wang CHEN Qiang SHANG Yun-xiao WU Xing-dong YANG Qiao-zhi YU Hui ZHANG Ting YANG Tao
Infectious Diseases Diagnostic and Research Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, 100015,china
关键词:
手足口病指南抗病毒治疗
Keywords:
 hand foot and mouth disease guideline antiviral therapy
分类号:
R725.1
DOI:
10.3969/j.issn.1007-8134.2018.05.004
文献标识码:
A
摘要:
 2018 年5 月,国家卫生健康委员会官方发布了《手足口病诊疗指南(2018 版)》。该指南关于手足口病的 病因治疗(抗病毒治疗)部分指出,IFN-α 喷雾或雾化、利巴韦林静脉滴注早期使用可有一定疗效。本文主要解读手足 口病的抗病毒治疗,对IFN-α、利巴韦林以及新的抗EV-A71 药物作进一步阐述,同时对手足口病一般治疗予以解读。关 于重症手足口病的治疗,该指南叙述已经很详细,本文不再赘述。
Abstract:
 In May 2018, National Health Commission offically issued a new Guideline for the Diagnosis and Treatment of Hand Foot and Mouth Disease (2018 Version). As for etiological treatment of hand foot and mouth disease, this guideline indicates that IFN-α spray or atomization and early intravenous drip of ribavirin can be effective. In this paper, antiviral treatment of IFN-α, ribavirin and new anti-EV-A71 viral drugs are further elaborated, and general treatment of hand foot and mouth disease is interpreted. As for the treatment of severe hand foot and mouth disease, this guideline has described in detail and no repeated instructions will be given herein.  

参考文献/References


[1] 国家卫生健康委员会. 手足口病诊疗指南(2018 年版)[J].传染病信息,2018,31(3):193-198.
[2] 蒋荣猛,张育才,王荃,等. 手足口病的治疗[J]. 中国临床医生杂志,2018,46(7):763-767.
[3] Sasaki O, Karaki T, Imanishi J. Protective effect of interferon oninfections with hand, foot and mouth disease virus in newborn mice [J]. J Infect Dis, 1986, 153(3):498-502.
[4] Dias CC, Moraes MP, Weiss M, et al. Novel antiviral therapeutics tocontrol foot-and-mouth disease[J]. J Interferon Cytokine Res,2012, 32(10):462-473.
[5] Lin H, Huang L, Zhou J, et al. Efficacy and safety of interferon- α2b spray in the treatment of hand, foot, and mouth disease: amulticenter, randomized, double-blind trial[J]. Arch Virol,2016, 161(11):1-8.
[6] 曹琳,张磊,田莉,等. 重组人干扰素α2b 喷雾剂的抗病毒药效评价及临床观察[J]. 中国医药生物技术,2011,6(5):336-340.
[7] 宗文燕. 重组人干扰素α2b喷雾剂佐治手足口病疗效观察[J].河北医药,2011,33(18):2808-2809.
[8] Huang X, Zhang X, Wang F, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouthdisease with enterovirus 71 infection[J]. PLoS One, 2016,11(2):e0148907.
[9] 谭静,王武明,雷克竟. 丙种球蛋白静脉滴注联合干扰素雾化吸入治疗儿童重症手足口病疗效观察[J]. 儿科药学杂志,2017,(7):21-23.
[10] 张小丹,田亚坤,熊芳,等. 重组人干扰素α-2b 注射液雾化吸入治疗儿童手足口病的疗效观察[J]. 现代药物与临床,2014,29(4):404-407.
[11] 曾健生,钱素云. 重症手足口病的特点与诊治[J]. 中国急救医学,2008,28(8):752-753.
[12] 徐艳利,李颖,陈益平,等. 重组人干扰素α2b 喷雾剂治疗小儿手足口病有效性和安全性的多中心对照临床研究[J].中华传染病杂志,2018,36(2):101-106.
[13] 严彩平. 利巴韦林肌肉注射治疗儿童手足口病疗效及安全性分析[J]. 中国冶金工业医学杂志,2016 ,33(4):448.
[14] Li ZH, Li CM, Ling P, et al. Ribavirin reduces mortality inenterovirus 71-infected mice by decreasing viral replication[J].J Infect Dis, 2008, 197(6):854-857.
[15] WHO. WHO model list of essential medicines for children[EB/OL]. [2018-10-15]. http://apps.who.int/iris/bitstream/handle/10665/273825/EMLc-6-eng.pdf?ua=1&ua=1.
[16] Yu P, Bao L, Xu L, et al. Neurotropism in vitro and mouse modelsof severe and mild Infection with clinical strains of enterovirus 71 [J]. Viruses, 2017, 20, 9(11):pii:E351.
[17] Xing J, Liu D, Shen S, et al. Pathologic studies of fatalencephalomyelitis in children caused by enterovirus 71[J]. AmJ Clin Pathol, 2016, 146(1):95-106.
[18] 李亚男,徐晨,高向东. 肠道病毒71 型感染治疗方法研究进展[J]. 国际药学研究杂志,2016,43(5):829-836.
[19] Tijsma A, Franco D, Tucker S, et al. The capsid binder vapendavirand the novel protease inhibitor SG85 inhibit enterovirus71 replication[J]. Antimicrob Agents Chemother, 2014,58(11):6990-6992.
[20] Zhang X, Song Z, Qin B, et al. Rupintrivir is a promising candidatefor treating severe cases of enterovirus-71 infection: evaluation ofantiviral efficacy in a murine infection model[J]. Antiviral Res,2013, 97(3):264-269.
[21] Nisrine F, Roland M, Virginie L, et al. Blocking human enterovirus71 replication by targeting viral 2A protease[J]. J AntimicrobChemother, 2012, 67(12):2865-2869.
[22] Zhang X, Wang H, Li Y, et al. Novel substituted heteroaromaticpiperazine and piperidine derivatives as inhibitors of humanenterovirus 71 and coxsackievirus A16[J]. Molecules, 2013,18(5):5059-5071.
[23] Xie S, Wang K, Yu W, et al. DIDS blocks a chloride-dependentcurrent that is mediated by the 2B protein of enterovirus 71[J].Cell Research, 2011, 21(8):1271-1275.
[24] Arita M, Wakita T, Shimizu H. Characterization of pharmacologicallyactive compounds that inhibit poliovirus and enterovirus 71infectivity[J]. J Gen Virol, 2008, 89(Pt 10):2518-2530.
[25] Arita M, Takebe Y, Wakita T, et al. A bifunctional anti-enteroviruscompound that inhibits replication and the early stage of enterovirus71 infection[J]. J Gen Virol, 2010, 91(Pt11):2734-2744.
[26] Chen T, Chang H, Lin P, et al. Novel antiviral agent DTriP-22targets RNA- dependent RNA polymerase of enterovirus 71[J].Antimicrob Agents Chemother, 2009, 53(7):2740-2747.

备注/Memo

备注/Memo:
[ 基金项目] 北京市医院管理局“扬帆”计划重点医学专业项目 (ZYLX201602)
[ 作者单位] 100015,首都医科大学附属地坛医院感染性疾病诊 疗中心(蒋荣猛、李兴旺);710000,西安市儿童医院感染科 (邓慧玲);330006 南昌,江西省儿童医院呼吸科(陈强); 110004 沈阳,中国医科大学附属盛京医院小儿呼吸科(尚云晓); 361000,厦门市妇幼保健院儿科(吴星东);252000,聊城市 人民医院儿科(杨巧芝);201102 上海,复旦大学附属儿科 医院感染科(俞蕙);200062,上海交通大学附属儿童医院 消化科(张婷);650051,昆明市延安医院儿科(杨涛)
更新日期/Last Update: 2018-10-30